author,created_utc,domain,id,is_self,num_comments,over_18,permalink,retrieved_on,score,selftext,stickied,subreddit_id,title,url
ArcticPlatypus,1681494522,self.NooTopics,12m5je1,True,12,False,/r/NooTopics/comments/12m5je1/roxadustat_dosing_schedule/,1709901425,6,"Iâ€™m very curious about Roxadustat and itâ€™s unique mechanism as a HIF prolyl hydroxylase inhibitor to possibly boost cognitive function and exercise performance through increased levels of Erythropoietin. Iâ€™ll most likely place an order for some soon but Iâ€™m not sure what the optimal dosing protocol is. It appears that studies have used a 3 times per week dosing schedule at varying dosages. Looks like 50 mg three times per week is on the low end, 70 mg might be optimal, and then 100-120 ish mg was more effective for people who had already been exposed to Erythropoietin itself. 

I want to make sure that I have these dose ranges correct and that 70 mg three times per week might be optimal. Or is a higher dose than that more effective specifically for cognitive enhancement purposes?",False,t5_4aoxhu,Roxadustat dosing schedule?,https://www.reddit.com/r/NooTopics/comments/12m5je1/roxadustat_dosing_schedule/
BrendenHenry,1681475926,self.NooTopics,12lvvjq,True,35,False,/r/NooTopics/comments/12lvvjq/pinealon_improves_cognition_and_performance_in/,1709901425,61,"Post Updated as of 2/15/2024

**Unleashing the Power of Pinealon: A Personal Journey**

On my quest for cognitive enhancement and overall well-being, I stumbled upon a peptide that would forever change my life, Pinealon. This one stood out as special to me because it was one of the few Khavinson peptides which had a plethora of research backing it, if you know where to look that is. 

And being a health-obsessed engineer (with OCD) and with backdoor access to the most cutting-edge scientific literature in the world, I was able to dive deeper into this than most people ever could.

In a world that is getting increasingly challenging to navigate, we need to be as cognitively enhanced as possible, and I feel it's my duty to share my knowledge and experiences to help you evolve every day and conquer your limits, which is why I'm sharing this blog post with you today.

The first time I ordered Pinealon, it almost slipped through my fingers. Misdelivered from my address, I was initially crestfallen, but my curiosity and determination drove me to extraordinary lengths. I began a door-to-door search, knocking on neighbors' doors in the hope of reclaiming it. After leaving messages and exhausting all avenues, one neighbor came through, returning the misdelivered package.

That night, with Pinealon in hand, I decided to experiment with it as a nasal spray. The effects were nothing short of remarkable. As rain pattered against the window and darkness enveloped the world outside, I felt a subtle shift in my mood, a gentle wave of bliss washing over me. Colors seemed more vivid, sounds more vibrant, and my mind, astonishingly clear-headed.

Driven by newfound energy and clarity, I decided on a workout, eager to put Pinealon's reputed physical enhancing properties to the test. The workout felt great as my muscles didn't seem to tire as fast and as you'll discover in today's blog post, Pinealon not only enhances cognitive function but also physical endurance and performance. 

&#x200B;

&#x200B;

&#x200B;

**Introduction:**

Pinealon is a Cytogen also known as 'EDR,' it is composed of the amino acid sequence Glu-Asp-Arg and has a molecular weight of 418.41. Contrary to its name and certain influencer claims, Pinealon's origin isn't in the pineal gland. This cytogen finds its roots in cortexin Â¹, indicating that it is naturally present in bovine or porcine cortex, specifically those less than 1 year old. Pinealon is the most powerful Khavinson peptide for enhancing cognition and improving physical performance in healthy individuals based on currently available data. It also demonstrates potent Gero protective and neuroregenerative effects, capable of completely reversing damage caused by Alzheimer's and Huntington's diseases in vitro Â²Â³ Â²â´. Similar to all of Khavinson's peptides, its mechanisms of action within the body involve ligand binding to various DNA promoter regions, influencing the expression of various genes.

&#x200B;

&#x200B;

&#x200B;

**Mechanisms of action:**

With Pinealon's remarkable capacity to directly enhance gene expression in mind, let's delve into some of the genes it regulates, offering us a clearer understanding of how it exerts its effects.

**GDF11**

â¦ Pinealon possesses a binding site within GDF11 and has been observed to provide similar benefits to GDF11, including an increase in its expression âµÂ³.

While the full study ""[GDF11 protein as a geroprotector](https://link.springer.com/article/10.1134/S207908641602002X)"" is available through paid access only, having read the full study, Khavinson discusses how GDF11 was responsible for some cognitive improvement, age reversal, and health improvement effects, particularly in blood transfusions from young to older individuals. Of particular interest may be its ability to reverse cardiac hypertrophy, as seen in a screenshot from the study below:

ðŸ“·

&#x200B;

&#x200B;

As mentioned, GDF11 is considered a rejuvenation factor in old age âµâ´. It retards the aging process in male mice âµâµ and reduces the depression phenotype in old mice by promoting neural autophagy âµâ¶. Additionally, it plays a crucial role in stem cell production and DNA repair. However, it's worth noting that GDF11 levels tend to decline to near-zero at an average age of 73.71 years old â¶â¹. GDF11 has been shown to increase vasculature in the hippocampus and cortex of old mice when administered systemically. Still, it does not cross the blood-brain barrier (BBB) in appreciable quantities â·Â¹. It shows benefits in spinal cord injury â·Â³. Higher GDF11 is associated with reduced incidence of cardiovascular events and death â·Â², and it's known for regenerating myocardial tissue after ischemic injury â·âµ. GDF11 is also a positive regulator of muscle growth â¶â° and reverses age-related dysfunction in muscle â·â´. It increases wound healing in diabetic mice â·â¶, shows anti-aging benefits to the skin â·â·, and shows promise in AD â·â¸.

One important aspect I'd like to address concerning GDF11 is its impact on liver autophagy. It tends to decrease autophagy in the liver due to increased mTOR1C activation â¹â¹. However, it's worth noting that rapamycin-induced autophagy can counteract this effect. Additionally, Pinealon activates alternative pathways, such as irisin and PPARs, which actually promote hepatic autophagy. Therefore, it shouldn't raise concerns.

When examining these ""bioregulator"" peptides like Pinealon, it's essential to consider the broader context rather than focusing solely on a specific gene in isolation. Given its natural origin in young and healthy animals, it's unlikely to be detrimental to health. This is one of the reasons why Khavinson's peptides are known for their absence of side effects.

&#x200B;

&#x200B;

&#x200B;

**FKBP1B**

â¦ Pinealon binds to the histone H1.3 protein and increases the expression of the FKBP1b gene â´â¶. FKBP1b has been shown to reverse age-related intracellular Ca2+ dysregulation, cognitive and memory impairments in aging rats, and restore the expression of 872 out of 876 genes in the direction opposite of aging in the hippocampus of mice, which are associated with structure categories including cytoskeleton, membrane channels, and extracellular region â´â¹. Early AD also shows downregulated FKBP1B â´â· â´â¸.

**PPAR's**

â¦ Pinealon significantly upregulates PPARA/G genes in humans and improves the performance of wrestlers Â¹Â¹ âµâ°. The PPARA/G genes have strong associations with athletic performance âµâ¸. PPARG upregulation is a potential target to benefit spinal cord injury â¸Â². PPAR gene polymorphisms associated with the ""g"" allele result in decreased function and have a high correlation to reduced hand grip strength â¸â¹, increased risk of breast cancer â¹â°, and AD âµÂ¹. PPARA also has an important role in regulating autophagy and clearing AB plaques by increasing the microglia and astrocytes around the AB plaques and enhancing the formation of autophagosomes â¶Â¹.

**HSPA1A**

â¦ Pinealon upregulates HSPA1A by about 3x in humans, though the dosage used was not specified Â¹Â¹ âµâ°. It codes for heat shock protein 70 and is associated with the learning process in mice put through the Morris water maze â¸â¸. It improves insulin sensitivity and decreases lipids, including within the brain âµÂ². It improves wound healing in vivo â¸âµ, promotes proper AR function Â¹â°Â¹, prevents muscular dystrophy, and enhances muscle hypertrophy Â¹â°Â², as well as spermatogenesis Â¹â°Â³. It prevents aggregation of misfolded proteins such as what occurs in AD, Huntington's disease, and PD â¸Â³, possibly partially through decreased cdk5 â¹â¶ which also improves resistance to oxidative stress and an increase in SIRT1 â¹â¸. Lower levels of heat shock protein 70 are also associated with ADHD in children, hinting that its upregulation may play a role in benefiting ADHD â¹â·.

**FNDC5/Irisin**

â¦ Pinealon increases FNDC5 gene expression, by binding to the gene in 5 regions, which codes for Irisin Â²â¶. Irisin is a positive regulator of muscle growth âµâ¹, restores nucleus pulposus cells in mice and stops disc degeneration â·â¹, and protects against motor dysfunction in rats with spinal cord injury â¸â°. It has been shown to increase telomerase and therefore the Hayflick limit Â²â¶, as well as SIRT1 â¸â¶, a longevity and anti-cancer pathway that activates caspases in cancer cells specifically but not healthy cells â¸â·. Irisin stimulates mitochondrial biogenesis and mitophagy â¹âµ, prevents mitochondrial damage in PD â¸â´, and provides potent antioxidant effects and reduces ferroptosis in hypoxia Â²â¸.

**Caspase 3**

â¦ Pinealon is able to bind directly to CASP3 Â³â° and reduce caspase 3 expression Â³Â¹, which is a regulator of apoptosis under hypoxia Â²â¹, and it was found to be the best peptide tested for hypoxia Â³Â². Inhibition of caspase 3 results in the upregulation of mitochondrial complex 1 of the electron transport chain, leading to increased ATP Â³Â³. In spinal cord injury, caspase 3 is upregulated and leads to cell death, suggesting that lowering it can assist in spinal cord injury â¸Â¹. In AD, caspase 3 activation has been shown to occur in dendritic spines in the hippocampus, leading to activation of calcineurin and phosphorylation of glur1, causing spine degeneration and memory deficits. Caspase 3 inhibition rescues these deficits Â³â´. Caspase 3 inhibition is also associated with pinealon's purported ability to regenerate the skin â·â°.

**TPH1/Serotonin**

â¦ Pinealon forms a hydrogen bond in the CCTGCC promoter region of the TPH1 gene, which increases its expression. This leads to increased serotonin synthesis within cultured cerebrocortical neurons of mice origin Â². In humans, the TPH1 gene has been found to have low expression in the cortex but high expression in the midbrain, such as the raphe nuclei Â³. Therefore, it is logical to assume that increased serotonin synthesis would primarily occur in the midbrain in humans. For an overview of serotonin synthesis â´.

&#x200B;

&#x200B;

&#x200B;

**Pinealon enhances cognition, mood, TBI recovery, protects from hypoxia, reverses neurodegeneration, and improves physical performance.**

â¦ Improved intellectual markers in male wrestlers and older men Â¹Â¹.

â¦ Improved spatial orientation and attention in aging rhesus monkeys while increasing the speed of learning by 1.5x Â¹â°.

â¦ Improved mice performance in the Morris water maze and was associated with increased Nr2a/Nr2b ratio. The enhanced memory was retained even after streptozotocin-induced diabetes â¸.

* Conferred neuroprotection to NMDA receptors by inhibiting the deleterious effects of high homocysteine, through preventing homocysteine's activation of ERK1/2 in NMDAR's Â¹â°â°. It was noted more effective than carnosine for this purpose and at much lower concentrations.

â¦ Improved rats' performance in the water maze in comparison to cortexin â¹.

â¦ Improved asthenic symptoms and psych emotional state in workers under stressful conditions Â¹Â².

â¦ In TBI, Pinealon improved memory, lowered intensity and duration of headaches, increased emotional stability, and improved sense of well-being and being rested after a night's sleep, accounting for Pinealon's regenerative properties âµâ·.

â¦ Protects rat offspring from prenatal hyperhomocysteinemia â¶â¶, prenatal hypoxia â¶â·, and in vivo hypobaric hypoxia, doubling the time needed for rats to reach respiratory arrest â¶â¸.

â¦ Pinealon is shown to completely reverse the damage to mushroom spines in hippocampal cultures treated with AÎ²42 in the amyloid synaptotoxicity AD model Â²Â³, completely restores the damage to dendritic spines in Medium Spiny Neurons in an in vitro model of Huntington's disease Â²â´, and improves locomotion and accuracy of movements in a flying insect model of Parkinson's disease Â²âµ.

â¦ Increases athletes' performance, breath-holding time, and decreases markers of biological aging Â¹Â¹.

&#x200B;

&#x200B;

&#x200B;

**More on the significant physical performance enhancement**

ðŸ“·

Furthermore, in rats that were running on treadmill until exhaustion, it increased the time ran by up to 254%. However it should be noted that it was injected in this study at an unknown dosage.

ðŸ“·

Pinealon also increased heart rate power curves in athletes. The heart rate was 10-12 beats per minute lower while exerting the same power output.

ðŸ“·

Pinealon significantly heightens PPARA/G genes in humans which are associated with exercise performance. Additionally, Pinealon boosts FNDC5 gene expression, activating irisinâ€”a myokine released by muscle cells during exercise. This, in turn, triggers increased glucose uptake into muscle cells during and after training, mediated by the upregulation of glucose transporter GLUT4 through AMPK activation. This synergy enhances exercise effects and improved performance.

&#x200B;

&#x200B;

&#x200B;

**Pinealon vs SSRIs:**

Pinealon only enhances the synthesis of serotonin through TPH1, rather than inhibiting SERT. It may have a low incidence of sexual side effects because TPH1 is expressed in the hypothalamus Â³, where it's shown to be a potential target to decrease neuroendocrine disruption âµ. SSRIs decrease rats' performance in the Morris water maze test â¶, which is used to evaluate spatial memory and learning. SSRIs are generally associated with memory impairments in humans, though not always â·. Pinealon has been shown to improve healthy mice and rats' performance in the water maze test â¸ â¹and improve some intellectual functions in wrestlers Â¹Â¹.

&#x200B;

&#x200B;

&#x200B;

**Pinealon vs Cortexin:**

Pinealon has been shown to stimulate proliferative activity of neurons more than cortexin, as indicated by increased ki-67 and vimentin. Pinealon has also shown to reduce apoptosis more than cortexin as indicated by reduced p53 expression.

ðŸ“·ðŸ“·

As mentioned earlier, pinealon is also shown to improve cognition in healthy humans Â¹Â¹. and improves mice performance in the water maze test more than cortexin â¹.

&#x200B;

&#x200B;

&#x200B;

**ERK1/2 activation:**

Serotonin signals through GPCRs to increase cAMP levels Â¹Â³, which activates PKA, which phosphorylates CREB. CREB plays a role in LTP, which is believed to be a cellular basis for learning and memory Â¹â´. PKA can activate the ERK1/2 pathway directly Â¹âµ, or it can be activated in some 5-HT receptors through GPCRs, Î²-arrestins, and small GTPases Â¹âµ. ERK1/2 is not associated with an increase in inflammatory cytokines, unlike other MAPKs such as p38 and JNK Â¹â¶. Irisin and ERK1/2, which pinealon also activates directly, can each reinforce the other Â²â· â´Â¹.

Activation of ERK1/2 influences cellular redox balance by activating NRF2, which in turn activates heme oxygenase 1, glutathione, catalase, and superoxide dismutase, all of which are antioxidants Â¹â·. Pinealon has been shown in a study of cerebellar neurons to activate ERK1/2, possibly through the mechanisms explained above, though it could be multifaceted, and this activation is at least partially responsible for protecting those cells in a dose-dependent manner from hydrogen peroxide Â¹â¸. However, pinealon's speculated ability to bind to three regions in the GPX1 gene, which code for glutathione, and regions in the SOD1 gene which code for superoxide dismutase, may also contribute to its demonstrated antioxidant effect Â¹â¹(table 1).

&#x200B;

&#x200B;

&#x200B;

**Pinealon in AD:**

The above study showing protection from H2O2 is relevant to AD, as oxidative stress is one of the theories implicated in AD Â²â°, and H2O2 is generated during the early stages of aggregation of amyloid plaques associated with AD Â²Â¹. According to the A1 astrocyte theory, damage caused by amyloid plaques can trigger microglia to release pro-inflammatory cytokines, chemokines, and ROS, thereby leading to A1 type astrocytes, which ultimately cause neurons and oligodendrocytes to self-destruct. This phenomenon is also seen in Parkinson's disease and Huntington's disease Â²Â².

The hippocampus is the main brain region where neurogenesis can still occur throughout adulthood. It has been found that reductions in hippocampal neurogenesis may contribute to cognitive impairments, tau hyperphosphorylation in neurons, and compromised hippocampal circuitry in Alzheimer's disease Â³â¹ â´â°. When AÎ²42 peptide is added to a culture of neurons, inhibition of ERK1/2, PI3K/Akt, and consequently BDNF occurs, which leads to mitochondrial dysfunction, secretion of pro-inflammatory cytokines, and cell death â´âµ. GDF11 improves neurogenesis and vascularization â·Â¹ â·â¸, heatshock protein 70 prevents aggregation of misfolded proteins â¸Â³, PPARA improves the correct functioning of microglia and astrocytes â¶Â¹, non-amyloidogenic ERK1/2 Â³âµ Â³â¶ stimulates neurogenesis in the hippocampus, and Irisin additionally activates STAT-3 and BDNF in the hippocampus â´Â¹ â´Â². STAT-3 activation has also been shown to reverse cognitive deficits in AD by increasing NMDAR expression and synaptogenesis, which is inhibited in AD by increased oligomeric amyloid beta peptide that causes internalization of the receptor and weakens synapses â´Â³ â´â´. The ERK1/2 pathway also stimulates oligodendrocytes to myelinate axons, protecting neurons Â³â·. Myelination is reduced in Alzheimer's disease and ERK1/2 restores myelination Â³â¸. It is through these mechanisms and all of the above targets, such as GDF11, FKBP1B, HSPA1A, and PPARA/G, that may contribute to the complete regeneration seen in Ab42 toxicity model.

&#x200B;

&#x200B;

&#x200B;

**Pinealon in Parkinson's:**

As for how Pinealon improved symptoms in Parkinson's disease Â²âµ and increased DOPA and Dopamine â¶âµ, there are two potential mechanisms outside of the earlier noted regenerative abilities. Pinealon was shown to have a binding site within the CALM1 gene â¶â´, which codes for calmodulin. The binding analysis did not state whether it increased or decreased its activity. Since calmodulin can bind to Gi proteins in the D2 receptor and reduce its signaling through a cAMP mechanism, it is possible that Pinealon decreased CALM1 and hence led to an increase in D2 signaling â¶Â². This would explain the enhanced locomotion and accuracy of movements witnessed in flying insects. However, there is also the fact that PPARA regulates cholinergic-driven activity of midbrain dopamine through a mechanism involving Î±7 nicotinic receptors â¶Â³. This would also make sense as Î±7 agonists showed benefits in PD.

&#x200B;

&#x200B;

&#x200B;

**ROA and Dosing:**

Pinealon has been studied orally and intramuscularly; however, I believe that intranasal administration may be necessary to get the most out of the cognitive benefits. Considering GDF11 cannot cross the BBB in appreciable quantities, it makes sense that directly increasing its expression in the brain, perhaps through Pinealon, could lead to farther-reaching benefits than what were seen in neuro-studies. I had one concern that Pinealon may result in increasing the expression of the TPH1 gene in the gut, which can potentially decrease bone mass â¹Â¹ and hinder metabolic function â¹Â², even though the increase in irisin would increase bone mass â¹Â³ and improve metabolic function â¹â´. However, in the athlete studies mentioned in which Pinealon significantly improved performance, it was administered orally. This once again emphasizes that we can't focus solely on a single gene but must consider the entire picture.

For subcutaneous/intramuscular injection 5+ mg has shown to work well for TBI. For a nasal spray, I can only share anecdotes from myself and others I've had try it, and we have found the best doses to be 2-6mg daily. For oral dosing, 1-2 capsules per day seems best.

You can get pinealon nasal spray on [everychem](https://everychem.com/product/pinealon-spray-solution-10mg-ml/), or alternatively try the capsules from garmonia ltd.

&#x200B;

Unleash your Vigor and conquer Your Limits,

\-Brenden Henry

&#x200B;

The original version of this post had some images embedded in it. For that version of the post you can go to- [https://unyieldingvigor.com/resources/b/pinealon-glu-asp-arg](https://unyieldingvigor.com/resources/b/pinealon-glu-asp-arg)

Sources-

[https://docs.google.com/document/d/1btoU6aouXMy1bE1ad3ETOvjEufUL3mA5iL0Onq4VDqU/edit?usp=sharing](https://docs.google.com/document/d/1btoU6aouXMy1bE1ad3ETOvjEufUL3mA5iL0Onq4VDqU/edit?usp=sharing)

&#x200B;",False,t5_4aoxhu,Pinealon Improves Cognition and Performance in Healthy Adults,https://www.reddit.com/r/NooTopics/comments/12lvvjq/pinealon_improves_cognition_and_performance_in/
hi_imandrew,1681403979,self.NooTopics,12kv2iz,True,2,False,/r/NooTopics/comments/12kv2iz/newmind_removed_cyclazodone_nmc_based_on/,1709901425,13,"As those of you experimenting with *Cyclazodone* have come to realize, *NewMind* no longer stocks it.

I thought it would be both interesting and important to have some kind of understanding as to why *NewMind* has decided to go in this direction and have emailed them asking for clarification.

Unfortunately, it seems the *FDA* is to blame.

*tl;dr*

**The** ***FDA*** **has pressured** ***NewMind*** **into removing** ***Cyclazodone*** **and** ***NMC*****. There is no legal requirement preventing** ***NewMind*** **from stocking them and it does not appear to be a sourcing issue.**

Below, are some excerpts from my email correspondence with *NewMind* asking why *Cyclazodone* was removed and if it would be available in the future.

***NewMind*** replied:

>*Cyclazodone* and *NMC*, unfortunately the removal from our catalog of these materials is permanent.  
>  
>While we believe it may be possible to offer these materials in the future, that will depend on **formal legal guidance and regulatory compliance** changes as stated.

I asked *NewMind* which changes and asked for confirmation that the removal ofÂ *Cyclazodone* and *NMC* was due to regulatory changes.

***NewMind*** replied:

>*We are imposing our own risk management system, based on* ***regulatory pressure from the FDA*** *on imported lots of raw material*, and sudden closures of many of our competitors.  
>  
>We are also going through **GMP Certification** \- these are the changes and our **catalog may be reshaped by emerging new policies**, raw material/restock and ordering prioritizations, **as well as any potential risk of legal recourse or regulatory pressure.**  
>  
>I'm sorry to sound maybe cryptic, but there's really no better way to explain it.  
>  
>Our new risk management system considers potential hazmat concerns for handling certain potentially bio-hazardous materials, as well as the **potential for customers to misuse or consume them** \- is another risk factor, for example.

So there you have it. Despite *Cyclazodone* not being regulated, the *FDA* has decided to single it out and managed to pressure (bully) *NewMind* into removing it nonetheless.

I wish *NewMind* would have been more upfront and transparent about the matter, but at least they were professional enough to email me back and provide some information.",False,t5_4aoxhu,NewMind Removed Cyclazodone & NMC based on Regulatory Pressure from the FDA,https://www.reddit.com/r/NooTopics/comments/12kv2iz/newmind_removed_cyclazodone_nmc_based_on/
